NEW YORK (GenomeWeb News) — Micron Products will make components for Osmetech’s Opti Tube and Opti Gene product lines for three years, Micron parent company Arrhythmia Research Technology said today.
Opti Tubes are made to replace glass capillaries that are used in the Roche LightCycler, ART said. The OptiGene is an instrument “designed to enable simple and complex molecular diagnostic tests” in small- to medium-sized hospitals.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

An opinion piece in the Guardian argues that President Donald Trump is uninterested in science and that might not be a bad thing for the field.

The San Francisco Chronicle reports the Veterans Affairs Health System is studying whether genetic testing can help prescribe better depression therapies.

Stat News reports that Spark Therapeutics' Luxturna is now being used to treat a wider array of patients.

In Genome Biology this week: transcription factor use among brittle stars, single-cell RNA sequencing strategy, and more.